Vividion and Celgene partner to develop small molecules

Vividion Therapeutics Inc. (San Diego, Calif.) and Celgene Corp. (NASDAQ:CELG) entered a four-year collaboration to discover and develop small molecules against

Read the full 211 word article

User Sign In